Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Apple (AAPL), Alphabet (GOOG), Pfizer (PFE) and Two Other Stocks are Trending Today

Pfizer Interested in Buying Medivation

Shares of Medivation Inc (NASDAQ:MDVN) have gained 1.55% today after a report from Reuters claimed that the company has been approached by Pfizer Inc. (NYSE:PFE) concerning a possible acquisition. On Friday, Medivation rejected Sanofi SA (ADR) (NYSE:SNY)’s bid of $9.3 billion for the company. A source told Reuters that Medivation is consulting its legal and financial advisers in light of Pfizer’s interest in the company. Sanofi meanwhile is said to have no plans to make a new bid and is waiting for Medivation to launch an auction. Pfizer Inc. (NYSE:PFE)’s interest in Medivation comes weeks after the company called off its $160 billion acquisition of Allergan PLC (NYSE:AGN) due to new U.S. Treasury tax rules which eliminated the benefits of the company’s planned inversion deal. Shares of Pfizer are 0.56% in the red today.

Pfizer ranked among the most popular stocks in our database, with 109 funds in our system holding around $8.6 billion worth of the company’s shares at the end of last year. Meanwhile, a total of 34 investors tracked by Insider Monkey held long positions in Medivation Inc (NASDAQ:MDVN) at the end of the last year, with the total value of their investments valued at approximately $138.8 million.

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.